BEAM icon

Beam Therapeutics
BEAM

Overview Fund Activity

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$294M
2
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$18.4M
3
EAM
3
Eventide Asset Management
Massachusetts
$12.7M
4
HRCM
4
Hood River Capital Management
Florida
$11M
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$24.3M

Top Sellers

1
Temasek Holdings
1
Temasek Holdings
Singapore
$137M
2
State Street
2
State Street
Massachusetts
$122M
3
AIM
3
ARK Investment Management
Florida
$405M
4
DTC
4
Deep Track Capital
Connecticut
$47.6M
5
Millennium Management
5
Millennium Management
New York
$8.01M
Name Market Value Shares Shares
Change 		Shares
Change %
CCM
251
Cribstone Capital Management
Maine
$0 9 – –
GWS
252
Glassman Wealth Services
Virginia
$0 3 – –
LFG
253
Larson Financial Group
Missouri
$0 10 – –
CAL
254
Capital Advisors Ltd
Ohio
$0 3 +3 New
7 8 9 10
11